PuSH - Publikationsserver des Helmholtz Zentrums München

Bornstein, S.R. ; Rubino, F.* ; Khunti, K.* ; Mingrone, G.* ; Hopkins, D.* ; Birkenfeld, A.L. ; Boehm, B.* ; Amiel, S.* ; Holt, R.I.* ; Skyler, J.S.* ; deVries, J.H.* ; Renard, E.* ; Eckel, R.H.* ; Zimmet, P.* ; Alberti, K.G.* ; Vidal, J.* ; Geloneze, B.* ; Ludwig, B.

Practical recommendations for the management of diabetes in patients with COVID-19.

Lancet Diabet. Endocrinol. 8, 546-550 (2020)
DOI Verlagsversion bestellen
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20-50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Coronavirus; Receptor
ISSN (print) / ISBN 2213-8587
e-ISSN 2213-8595
Quellenangaben Band: 8, Heft: 6, Seiten: 546-550 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Pancreatic Beta Cell Research (IPI)
Institute of Diabetes Research and Metabolic Diseases (IDM)